- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.68 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
TRS.14: 6 residues within 4Å:- Chain A: T.8, L.9, F.10, C.11, D.64, Y.101
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:L.9, A:C.11, A:D.64
TRS.15: 2 residues within 4Å:- Chain A: N.223, T.225
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:T.225, A:T.225
- Water bridges: A:N.223, A:S.325, A:S.325
- 7 x BGC: beta-D-glucopyranose(Non-covalent)
BGC.16: 7 residues within 4Å:- Chain A: D.114, N.116, F.117, N.118, T.120
- Ligands: NAG.3, BGC.17
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:D.114, A:N.116, A:N.118, A:N.118, A:N.118
BGC.17: 6 residues within 4Å:- Chain A: N.118, K.216, E.219, H.220
- Ligands: NAG.3, BGC.16
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:N.118, A:K.216
- Salt bridges: A:H.220
BGC.18: 7 residues within 4Å:- Chain A: L.79, G.81, T.291, G.292, Q.293
- Chain B: D.73, Y.75
4 PLIP interactions:4 interactions with chain A- Hydrogen bonds: A:L.79, A:G.81, A:Q.293, A:Q.293
BGC.19: 7 residues within 4Å:- Chain A: L.236, E.237, K.282, I.284, I.285, N.286, Q.293
8 PLIP interactions:8 interactions with chain A- Hydrogen bonds: A:E.237, A:K.282, A:I.285, A:N.286, A:Q.293
- Water bridges: A:L.236, A:N.286
- Salt bridges: A:K.282
BGC.20: 7 residues within 4Å:- Chain B: Q.1, V.2, R.98, K.100, E.109, H.110
- Ligands: BGC.21
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:Q.1, B:V.2, B:K.100, B:K.100, B:K.100
- Salt bridges: B:R.98, B:H.110
BGC.21: 7 residues within 4Å:- Chain B: Y.27, E.28, D.31, R.98, N.101, C.102
- Ligands: BGC.20
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:E.28, B:D.31, B:R.98, B:R.98, B:C.102
- Water bridges: B:G.26, B:K.100
BGC.22: 4 residues within 4Å:- Chain C: K.141, V.142, S.155, E.157
4 PLIP interactions:4 interactions with chain C- Hydrogen bonds: C:V.142, C:V.142, C:S.155, C:S.155
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, T. et al., Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science (2010)
- Release Date
- 2010-07-07
- Peptides
- Envelope glycoprotein gp160: A
Antigen binding fragment of heavy chain: Antibody VRC01: B
Antigen binding fragment of light chain: Antibody VRC01: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.68 Å
- Oligo State
- hetero-1-1-1-mer
- Ligands
- 1 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 12 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x TRS: 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL(Non-functional Binders)
- 7 x BGC: beta-D-glucopyranose(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, T. et al., Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01. Science (2010)
- Release Date
- 2010-07-07
- Peptides
- Envelope glycoprotein gp160: A
Antigen binding fragment of heavy chain: Antibody VRC01: B
Antigen binding fragment of light chain: Antibody VRC01: C - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C